{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:48:21Z","timestamp":1768438101003,"version":"3.49.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,9,10]],"date-time":"2013-09-10T00:00:00Z","timestamp":1378771200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Colorectal Dis"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1007\/s00384-013-1769-7","type":"journal-article","created":{"date-parts":[[2013,9,9]],"date-time":"2013-09-09T09:44:55Z","timestamp":1378719895000},"page":"111-116","source":"Crossref","is-referenced-by-count":43,"title":["Laparoscopic sphincter-preserving surgery (intersphincteric resection) after neoadjuvant imatinib treatment for gastrointestinal stromal tumor (GIST) of the rectum"],"prefix":"10.1007","volume":"29","author":[{"given":"Yoshiya","family":"Fujimoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Akiyoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Konishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Nagayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Fukunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,9,10]]},"reference":[{"key":"1769_CR1","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1572-0241.2005.40709.x","volume":"100","author":"T Tran","year":"2005","unstructured":"Tran T, Davila JA, El-Serag HB (2005) The epidemiology of malignant gastrointestinal stromal tumors: an analysis of 1,458 cases from 1992 to 2000. Am J Gastroenterol 100:162\u2013168","journal-title":"Am J Gastroenterol"},{"key":"1769_CR2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00000658-200001000-00008","volume":"231","author":"RP Dematteo","year":"2000","unstructured":"Dematteo RP, Lewis JJ, Leung D et al (2000) Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg 231:51\u201358","journal-title":"Ann Surg"},{"key":"1769_CR3","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1056\/NEJMoa020461","volume":"347","author":"GD Demetri","year":"2002","unstructured":"Demetri GD, von Mehren M, Blanke CD et al (2002) Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 347:472\u2013480","journal-title":"N Engl J Med"},{"key":"1769_CR4","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S0140-6736(04)17098-0","volume":"364","author":"J Verweij","year":"2004","unstructured":"Verweij J, Casali PG, Zalcberg J et al (2004) Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomized trial. Lancet 364:1127\u20131134","journal-title":"Lancet"},{"key":"1769_CR5","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.ejso.2008.11.005","volume":"35","author":"M Fiore","year":"2009","unstructured":"Fiore M, Palassini E, Fumagalli E et al (2009) Preoperative imatinib mesylate for unresectable or locally advanced primary gastrointestinal stromal tumors (GIST). Eur J Surg Oncol 35:739\u2013745","journal-title":"Eur J Surg Oncol"},{"key":"1769_CR6","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/jso.21160","volume":"99","author":"BL Eisenberg","year":"2009","unstructured":"Eisenberg BL, Harris J, Blanke CD et al (2009) Phase II trial of neoadjuvant\/adjuvant imatinib mesylate (IM) for advanced primary and metastatic\/recurrent operable gastrointestinal stromal tumors (GIST): early results of RTOG 0132\/ACRIN 6665. J Surg Oncol 99:42\u201347","journal-title":"J Surg Oncol"},{"key":"1769_CR7","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/COC.0b013e3181dea970","volume":"34","author":"JP Wang","year":"2011","unstructured":"Wang JP, Wang T, Huang MJ et al (2011) The role of neoadjuvant imatinib mesylate therapy in sphincter-preserving procedures for anorectal gastrointestinal stromal tumor. Am J Clin Oncol 34:314\u2013316","journal-title":"Am J Clin Oncol"},{"key":"1769_CR8","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1111\/j.1463-1318.2010.02442.x","volume":"13","author":"S Machlenkin","year":"2011","unstructured":"Machlenkin S, Pinsk I, Tulchinsky H et al (2011) The effective of neoadjuvant imatinib therapy on outcome and survival after rectal gastrointestinal stromal tumour. Color Dis 13:1110\u20131115","journal-title":"Color Dis"},{"key":"1769_CR9","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00464-007-9626-9","volume":"22","author":"H Kuroyanagi","year":"2008","unstructured":"Kuroyanagi H, Oya M, Ueno M, Fujimoto Y, Yamaguchi T, Muto T (2008) Standardized technique of laparoscopic intracorporeal rectal transection and anastomosis for low anterior resection. Surg Endosc 22:557\u2013561","journal-title":"Surg Endosc"},{"key":"1769_CR10","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s11605-009-1150-x","volume":"14","author":"Y Fujimoto","year":"2010","unstructured":"Fujimoto Y, Akiyoshi T, Kuroyanagi H et al (2010) Safety and feasibility of laparoscopic intersphincteric resection for very lower rectal cancer. J Gastrointest Surg 14:645\u2013650","journal-title":"J Gastrointest Surg"},{"key":"1769_CR11","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1056\/NEJM200104053441404","volume":"344","author":"H Joensuu","year":"2001","unstructured":"Joensuu H, Roberts PJ, Sarlom-Rikala M et al (2001) Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N Engl J Med 344:1052\u20131056","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"1769_CR12","doi-asserted-by":"crossref","first-page":"ii35","DOI":"10.1093\/annonc\/mdn080","volume":"19","author":"PG Casali","year":"2008","unstructured":"Casali PG, Jost L, Reichardt P, Schlemmer M, Blay JY, ESMO Guideline Working Group (2008) Gastrointestinal stromal tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 19(Suppl 2):ii35\u2013ii38","journal-title":"Ann Oncol"},{"issue":"Suppl 2","key":"1769_CR13","first-page":"S1","volume":"5","author":"GD Demetri","year":"2007","unstructured":"Demetri GD, Benjamin RS, Blanke CD et al (2007) NCCN task force report: management of patients with gastrointestinal stromal tumor (GIST)\u2014update of the NCCN clinical practice guidelines. JNCCN 5(Suppl 2):S1\u2013S29","journal-title":"JNCCN"},{"key":"1769_CR14","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/cncr.23199","volume":"112","author":"RP Dematteo","year":"2008","unstructured":"Dematteo RP, Gold JS, Saran L et al (2008) Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST). Cancer 112:608\u2013615","journal-title":"Cancer"},{"key":"1769_CR15","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1007\/s10350-004-0922-3","volume":"48","author":"SS Lo","year":"2005","unstructured":"Lo SS, Papachristou GI, Finkelstein SD et al (2005) Neoadjuvant imatinib in gastrointestinal stromal tumor of rectum: report of a case. Dis Colon Rectum 48:1316\u20131319","journal-title":"Dis Colon Rectum"},{"key":"1769_CR16","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/gut.2005.086744","volume":"55","author":"M Salazar","year":"2006","unstructured":"Salazar M, Barata A, Andre S et al (2006) First report of a complete pathological response of a pelvic GIST treated with imatinib as neoadjuvant therapy. Gut 55:585\u2013586","journal-title":"Gut"},{"key":"1769_CR17","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s00595-007-3585-6","volume":"38","author":"Y Ebihara","year":"2008","unstructured":"Ebihara Y, Okushiba S, Kawarada Y et al (2008) Neoadjuvant imatinib in a gastrointestinal stromal tumor of the rectum: report of a case. Surg Today 38:174\u2013177","journal-title":"Surg Today"},{"key":"1769_CR18","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.3748\/wjg.15.1910","volume":"15","author":"YY Hou","year":"2009","unstructured":"Hou YY, Zohu Y, Lu SH et al (2009) Imatinib mesylate neoadjuvant treatment for rectal malignant gastrointestinal stromal tumor. World J Gastroenterol 15:1910\u20131913","journal-title":"World J Gastroenterol"},{"key":"1769_CR19","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1007\/s00595-012-0134-8","volume":"42","author":"T Nakamura","year":"2012","unstructured":"Nakamura T, Mitomi H, Onozato W et al (2012) Laparoscopic resection of a gastrointestinal stromal tumor of the rectum after treatment with imatinib mesylate: report of a case. Surg Today 42:1096\u20131099","journal-title":"Surg Today"},{"key":"1769_CR20","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1245\/s10434-006-9228-0","volume":"14","author":"F Haller","year":"2007","unstructured":"Haller F, Detken S, Schulten HJ et al (2007) Surgical management after neoadjuvant imatinib therapy in gastrointestinal stromal tumours (GISTs) with respect to imatinib resistance caused by secondary KIT mutations. Ann Surg Oncol 14:526\u2013532","journal-title":"Ann Surg Oncol"},{"key":"1769_CR21","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1093\/annonc\/mdi127","volume":"16","author":"JY Blay","year":"2005","unstructured":"Blay JY, Bonvalot S, Casali P, GIST consensus meeting panelists et al (2005) Consensus meeting for gastrointestinal stromal tumours. Report of the GIST consensus conference of 20\u201321 March 2004, under the auspices of ESMO. Ann Oncol 16:566\u2013578","journal-title":"Ann Oncol"},{"key":"1769_CR22","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/01.sla.0000242710.36384.1b","volume":"245","author":"A Gronchi","year":"2007","unstructured":"Gronchi A, Fiore M, Miselli F et al (2007) Surgery of residual disease following molecular-targeted therapy with imatinib mesylate in advance\/metastatic GIST. Ann Surg 245:341\u2013346","journal-title":"Ann Surg"}],"container-title":["International Journal of Colorectal Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-013-1769-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00384-013-1769-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-013-1769-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T12:40:25Z","timestamp":1596458425000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00384-013-1769-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,10]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["1769"],"URL":"https:\/\/doi.org\/10.1007\/s00384-013-1769-7","relation":{},"ISSN":["0179-1958","1432-1262"],"issn-type":[{"value":"0179-1958","type":"print"},{"value":"1432-1262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,10]]}}}